Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1194

1.

Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations.

Parker DM, Tun STT, White LJ, Kajeechiwa L, Thwin MM, Landier J, Chaumeau V, Corbel V, Dondorp AM, von Seidlein L, White NJ, Maude RJ, Nosten F.

Elife. 2019 Apr 16;8. pii: e41023. doi: 10.7554/eLife.41023.

2.

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, Thinraow S, Wilairisak P, Raksapraidee R, Carrara VI, Paw MK, Wiladphaingern J, Proux S, Bancone G, Sriprawat K, Lee SJ, Jeeyapant A, Watson J, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2019 Apr 8;68(8):1311-1319. doi: 10.1093/cid/ciy735.

3.

Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia.

Duanguppama J, Mathema VB, Tripura R, Day NPJ, Maxay M, Nguon C, von Seidlein L, Dhorda M, Peto TJ, Nosten F, White NJ, Dondorp AM, Imwong M.

Malar J. 2019 Apr 2;18(1):114. doi: 10.1186/s12936-019-2749-3.

4.

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Mar 29;10(1):1433. doi: 10.1038/s41467-019-09441-1.

5.

Does reduced oxygen delivery cause lactic acidosis in falciparum malaria? An observational study.

Kingston HW, Ghose A, Rungpradubvong V, Herdman MT, Plewes K, Ishioka H, Leopold SJ, Maude RJ, Intharabut B, Mohanty S, Day NPJ, White NJ, Hossain MA, Anstey NM, Dondorp AM.

Malar J. 2019 Mar 25;18(1):97. doi: 10.1186/s12936-019-2733-y.

6.

Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region.

Pell CL, Adhikari B, Myo Thwin M, Kajeechiwa L, Nosten S, Nosten FH, Sahan KM, Smithuis FM, Nguyen TN, Hien TT, Tripura R, Peto TJ, Sanann N, Nguon C, Pongvongsa T, Phommasone K, Mayxay M, Mukaka M, Peerawaranun P, Kaehler N, Cheah PY, Day NPJ, White NJ, Dondorp AM, von Seidlein L.

PLoS One. 2019 Mar 25;14(3):e0214280. doi: 10.1371/journal.pone.0214280. eCollection 2019.

7.

Surgical outcomes of chronic isolated scapholunate interosseous ligament injuries: a systematic review of 805 wrists

Montgomery SJ, Rollick NJ, Kubik JF, Meldrum AR, White NJ.

Can J Surg. 2019 Mar 22;62(3):1-12. [Epub ahead of print]

PMID:
30900438
8.
9.

Efficacy of primaquine in preventing short and long latency Plasmodium vivax relapses in Nepal.

Rijal KR, Adhikari B, Ghimire P, Banjara MR, Thakur GD, Hanboonkunupakarn B, Imwong M, Chotivanich K, Day NPJ, White NJ, Pukrittayakamee S.

J Infect Dis. 2019 Mar 18. pii: jiz126. doi: 10.1093/infdis/jiz126. [Epub ahead of print]

PMID:
30882150
10.

Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk.

Ting LH, Feghhi S, Taparia N, Smith AO, Karchin A, Lim E, John AS, Wang X, Rue T, White NJ, Sniadecki NJ.

Nat Commun. 2019 Mar 13;10(1):1204. doi: 10.1038/s41467-019-09150-9.

11.

The rise and fall of long-latency Plasmodium vivax.

White NJ.

Trans R Soc Trop Med Hyg. 2019 Apr 1;113(4):163-168. doi: 10.1093/trstmh/trz002.

12.

Platelets retain inducible alpha granule secretion by P-selectin expression but exhibit mechanical dysfunction during trauma-induced coagulopathy.

St John AE, Newton JC, Martin EJ, Mohammed BM, Contaifer D Jr, Saunders JL, Brophy GM, Spiess BD, Ward KR, Brophy DF, López JA, White NJ.

J Thromb Haemost. 2019 Feb 19. doi: 10.1111/jth.14414. [Epub ahead of print]

PMID:
30784176
13.

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.

von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, Nosten S, Proux S, Corbel V, Tuong-Vy N, Phuc-Nhi TL, Son DH, Huong-Thu PN, Tuyen NTK, Tien NT, Dong LT, Hue DV, Quang HH, Nguon C, Davoeung C, Rekol H, Adhikari B, Henriques G, Phongmany P, Suangkanarat P, Jeeyapant A, Vihokhern B, van der Pluijm RW, Lubell Y, White LJ, Aguas R, Promnarate C, Sirithiranont P, Malleret B, Rénia L, Onsjö C, Chan XH, Chalk J, Miotto O, Patumrat K, Chotivanich K, Hanboonkunupakarn B, Jittmala P, Kaehler N, Cheah PY, Pell C, Dhorda M, Imwong M, Snounou G, Mukaka M, Peerawaranun P, Lee SJ, Simpson JA, Pukrittayakamee S, Singhasivanon P, Grobusch MP, Cobelens F, Smithuis F, Newton PN, Thwaites GE, Day NPJ, Mayxay M, Hien TT, Nosten FH, Dondorp AM, White NJ.

PLoS Med. 2019 Feb 15;16(2):e1002745. doi: 10.1371/journal.pmed.1002745. eCollection 2019 Feb.

14.

Plasmodium vivax relapse rates following falciparum malaria reflect previous transmission intensity.

Ashley EA, Phyo AP, Carrara VI, Tun KM, Nosten F, Smithuis F, White NJ.

J Infect Dis. 2019 Jan 29. doi: 10.1093/infdis/jiz052. [Epub ahead of print]

PMID:
30698794
15.

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.

Chotsiri P, Zongo I, Milligan P, Compaore YD, Somé AF, Chandramohan D, Hanpithakpong W, Nosten F, Greenwood B, Rosenthal PJ, White NJ, Ouédraogo JB, Tarning J.

Nat Commun. 2019 Jan 29;10(1):480. doi: 10.1038/s41467-019-08297-9.

16.

Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.

Watson JA, Leopold SJ, Simpson JA, Day NP, Dondorp AM, White NJ.

Elife. 2019 Jan 28;8. pii: e43154. doi: 10.7554/eLife.43154.

17.

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole.

Watson JA, Strub-Wourgraft N, Tarral A, Ribeiro I, Tarning J, White NJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02515-18. doi: 10.1128/AAC.02515-18. Print 2019 Apr.

18.

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

Intharabut B, Kingston HW, Srinamon K, Ashley EA, Imwong M, Dhorda M, Woodrow C, Stepniewska K, Silamut K, Day NPJ, Dondorp AM, White NJ; Tracking Resistance to Artemisinin Collaboration.

J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.

PMID:
30657916
19.

Tafenoquine - A Radical Improvement?

White NJ.

N Engl J Med. 2019 Jan 17;380(3):285-286. doi: 10.1056/NEJMe1816383. No abstract available.

PMID:
30650321
20.

Martial arts technique for control of severe external bleeding.

Slevin JP, Harrison C, Da Silva E, White NJ.

Emerg Med J. 2019 Mar;36(3):154-158. doi: 10.1136/emermed-2018-207966. Epub 2019 Jan 5.

PMID:
30612092

Supplemental Content

Loading ...
Support Center